Forum pracy nad projektem wskrzeszenia The Forge

[yoylqnqvwb]

Serum lipoprotein in liver disease patients and its mechanism


Liver disease decrease when the level of HDL-C Mrs HDLs-C. In chronic liver. Disease at the Zeyi liD-C reduction is more apparent. This is the differential diagnosis of acute and chronic liver disease provides the means and prompt the liver of patients with different HDL-C reduction is caused by different metabolic mechanisms. Most of the HDL produced in the liver,[link widoczny dla zalogowanych], they are under the effect of LCAT into HDk,[link widoczny dla zalogowanych], HDL | With triglyceride-rich lipoproteins and the role of lipoprotein lipase into HDL, ~ ld we think there may have targeted the liver in HDL. And HDL. Different metabolic pathways, and HDL. Metabolic pathways are more susceptible than HDLt of liver damage. So almost all kinds of liver diseases have different levels of HDL. A reduction of C, and in acute liver disease and severe stages of chronic liver disease,[link widoczny dla zalogowanych], dysfunction of liver cells, more serious,[link widoczny dla zalogowanych], thereby further affecting the Duo HD work for a C level. Acute liver disease HDL,-C and normal liver function had no correlation between, on the contrary, HDL: a C and GPT and total bilirubin were negatively correlated to ask. Prompted a large number of liver cell necrosis and cholestasis with HDLz-C reduction related. In chronic liver diseases HDL3-C was positively correlated with albumin, indicating that HDL. A C and slow liver injury caused by the reduction of protein synthesis in the liver and lipid dysfunction. As part of the HD work spit from triglyceride-rich lipoproteins in plasma 【lack of correlation with serum albumin of Clinical Hepatology 1990,[link widoczny dla zalogowanych], 6 No. 1 reason.